Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04832 |
| Species: | Homo sapiens |
| Position : | chr3:150450617-150456921 |
| Year: | 2018 |
| Title: | JMJD6 Licenses ER汐-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Breast Cancer |
| PMID: | 29628309 |
| MONDO: | MONDO:0007254 |
| Tissue: | breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MCF-7 |
| CVCL ID: | CVCL_0031 |
| Experiment Type: | TF-binding/chromatin assay; Disease-associated enhancer analysis |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | ChIP-qPCR/ChIP; RT-qPCR/qPCR; RNAi/siRNA/shRNA |
| Target gene : | SIAH2 |
| TF name : | JMJD6 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| JMJD6 | HDMs demethylate histones | reactome | 49 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04831 | chr3:150450617-150456921 | breast | NA | Breast Cancer |